Shares of Catasys Inc. (NASDAQ:CATS) have received a consensus broker rating score of 1.00 (Strong Buy) from the one brokers that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a strong buy rating.

Brokers have set a 12-month consensus target price of $12.00 for the company, according to Zacks. Zacks has also assigned Catasys an industry rank of 63 out of 265 based on the ratings given to its competitors.

Separately, Zacks Investment Research raised shares of Catasys from a “sell” rating to a “hold” rating in a research note on Monday, August 7th.

Shares of Catasys (CATS) remained flat at $5.33 during mid-day trading on Friday. The company’s stock had a trading volume of 38,384 shares. The firm has a 50-day moving average of $4.76 and a 200-day moving average of $6.09. Catasys has a 12-month low of $3.56 and a 12-month high of $14.00. The firm’s market cap is $84.69 million.

Catasys (NASDAQ:CATS) last announced its earnings results on Tuesday, August 15th. The company reported ($0.23) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.20) by $0.03. The firm had revenue of $1.67 million for the quarter. Equities analysts anticipate that Catasys will post ($1.26) earnings per share for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Perkins Capital Management Inc. bought a new stake in Catasys in the second quarter valued at approximately $113,000. Bard Associates Inc. bought a new stake in Catasys in the second quarter valued at approximately $1,012,000. FNY Partners Fund LP bought a new stake in Catasys in the second quarter valued at approximately $1,560,000. UBS Oconnor LLC bought a new stake in Catasys in the second quarter valued at approximately $834,000. Finally, Kennedy Capital Management Inc. bought a new stake in Catasys in the second quarter valued at approximately $1,385,000. 7.16% of the stock is owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: This article was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/09/11/catasys-inc-cats-given-12-00-average-price-target-by-brokerages.html.

Catasys Company Profile

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for Catasys Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys Inc. and related stocks with our FREE daily email newsletter.